Best Practices in the Diagnosis and Management of Homozygous Familial Hypercholesterolemia: Towards Individualized Treatment Strategies

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 90 Minutes

Overview

This roundtable discussion with expert faculty will provide learners with the latest advances in diagnosing and managing patients with Homozygous Familial Hypercholesterolemia (HoFH). The goal of the activity is for learners to be better able to recognize the signs and symptoms of HoFH, the diagnostic criteria for this disease, the recommendations for cascade screening, as well as current strategies for individualizing treatment of HoFH in children and adults, including a review of angiopoietin-like 3 (ANGPTL3) inhibitors and it’s role in the management of HoFH.

Learning Objectives

  1. Implement strategies for the timely diagnosis of homozygous familial hypercholesterolemia (HoFH)
  2. Discuss the role of cascade screening in identifying patients with HoFH
  3. Integrate currently approved therapies for the treatment of HoFH
  4. Individualize treatment for patients with HoFH based on response to therapy and/or disease genetics

Target Audience

This activity is intended for cardiologists, lipidologists, endocrinologists, internists, infusion center nurses, pediatricians, and other healthcare providers involved in the care of patients with FH, including HoFH.

This activity is supported by an independent medical educational grant from Regeneron Pharmaceuticals, Inc.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
10/30/2023
Course expires: 
11/28/2024
Cost:
$0.00
Rating: 
5

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above